Altamira Therapeutics Ltd - Company Profile
Powered by 
All the data and insights you need on Altamira Therapeutics Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Altamira Therapeutics Ltd Strategy Report
- Understand Altamira Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Altamira Therapeutics Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 25 Mar 2024 | Altamira Therapeutics Enters into Agreement Univercells | Partnership | - |
Altamira Therapeutics Ltd
Univercells SA
|
| 19 Jan 2024 | Altamira Therapeutics to Raise Up to USD1.66 Million in public offering of common stock | Equity Offering | - |
Altamira Therapeutics Ltd |
| 17 Nov 2023 | Altamira Therapeutics Partial Spins-Off with Altamira Medica | Equity Offering | - |
Altamira Medica AG
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer